U.S., Oct. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07213700) titled 'InRAD Observational Study' on Sept. 23.
Brief Summary: The goal of this international observational study is to evaluate long-term disease outcomes and treatment safety in people with Alzheimer's disease (PwAD), by collecting real-world data from routine clinical practice across global clinical centers.
The InRAD Registry Observational Study has several aims:
* To collect medical information for many years from a large group of people with Alzheimer's disease. This will be used for research, which will support improved understanding about the disease.
* To enable researchers to look at the effectiveness, usefulness and safety of ...